Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.08M P/E - EPS this Y 17.50% Ern Qtrly Grth -
Income -6.24M Forward P/E - EPS next Y 38.50% 50D Avg Chg -40.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 2.45 EPS next 5Y - 52W High Chg -87.00%
Recommedations 2.00 Quick Ratio 3.44 Shares Outstanding 1.07M 52W Low Chg 4.00%
Insider Own 46.72% ROA -91.90% Shares Float 568.58K Beta -
Inst Own 2.19% ROE -174.01% Shares Shorted/Prior 19.35K/4K Price 0.85
Gross Margin - Profit Margin - Avg. Volume 390,282 Target Price 45.00
Oper. Margin - Earnings Date - Volume 53,124 Change -2.31%
About Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Cadrenal Therapeutics, Inc. News
11/20/24 CVKD: Recent Financings Raise $9.8 Million…
11/19/24 Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
11/12/24 CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
11/07/24 CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
11/01/24 Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
10/28/24 We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate
10/24/24 Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
08:00 AM CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
03:15 PM Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference
09/16/24 CVKD: New Blood Thinner Ready for Phase 3; Initiating Coverage of Cadrenal Therapeutics, Inc…
09/11/24 Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
08/22/24 Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients
08/20/24 Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
08/20/24 Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
08/14/24 Cadrenal Therapeutics to Present at Upcoming Investor Conferences
08/12/24 Cadrenal Therapeutics, Inc. (CVKD): A New Penny Stock to Buy Now
08/07/24 Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update
08/07/24 CVKD: Cadrenal Therapeutics and Abbott Collaborate on Novel Anticoagulant for LVAD Patients
08/06/24 Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
07/17/24 Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024
CVKD Chatroom

User Image Stocksrockman Posted - 6 hours ago

$ABVE AI play🔥 $lixt and $MIGI are both bullish $CVKD and $ANTE uptrend

User Image Greywolf11 Posted - 1 day ago

$CVKD adding before the next big wave

User Image StockQuen Posted - 1 day ago

NASDAQ: $CVKD Pick Up This Morning Breaking NEWS:🚨 Cadrenal Therapeutics Wins "Anticoagulation Therapy Company of the Year" Innovation: Tecarfarin minimizes drug interactions, improves stability, and suits patients with kidney impairment.

User Image HotStockNews Posted - 1 day ago

NASDAQ: $CVKD TODAY BIG NEWS:🚨 ''Cadrenal Therapeutics Wins 2024 Anticoagulation Therapy Company of the Year'' $CVKD -Hc Wainwright raises Cadrenal Therapeutics price target to $32 from $3

User Image StockQuen Posted - 1 day ago

NASDAQ: $CVKD BIG NEWS🚨 Cadrenal Therapeutics Wins 2024 Anticoagulation Therapy Company of the Year Award: Recognized by Pharma Tech Outlook for pioneering tecarfarin, a safer alternative to warfarin for patients with LVADs and rare cardiovascular conditions.

User Image HotStockNews Posted - 1 day ago

NASDAQ: $CVKD BIG NEWS: Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook Add Now $CVKD, ANOTHER BIG WAVE COMING

User Image ShortSqueeze10X Posted - 1 day ago

$CVKD Volume 13,777 Avg. Volume 57,687

User Image bulltradrr Posted - 2 days ago

$CVKD bounce back

User Image Cashcowtipper Posted - 2 days ago

$CVKD

User Image PaidBashar Posted - 2 days ago

$CVKD i am not convinced that most of you know what happens to this over the course of the next year trail of tears

User Image Jizzle14 Posted - 3 days ago

$CVKD BUY ZONE!

User Image JerryOLarry Posted - 3 days ago

$CVKD Rad.......

User Image BHWinehouse Posted - 3 days ago

$ELAB The last RS I went through was $CVKD in August, now up over 100%. Both have a multi billion dollar drug in the works. Research the pipeline and wait.

User Image catchAfeeling Posted - 4 days ago

$IBG $KAPA $CVKD

User Image Dazkusmoney Posted - 4 days ago

$CVKD Our uptrend support has been broken. We ‘could’ see some potential downward moves if no news. Hopefully we still have strong support at $15.

User Image bulltradrr Posted - 4 days ago

$CVKD this is huge

User Image bulltradrr Posted - 4 days ago

$CVKD https://www.prnewswire.com/news-releases/cadrenal-therapeutics-named-anticoagulation-therapy-company-of-the-year-by-pharma-tech-outlook-302309432.html

User Image harmeyerc Posted - 4 days ago

$CVKD Right on que, great honor and recognition and share price drops. MM's have to get their buddies some cheaper shares before they run it up 😉

User Image EfamhS Posted - 4 days ago

$CVKD https://www.cadrenal.com/cadrenal-therapeutics-named-anticoagulation-therapy-company-of-the-year-by-pharma-tech-outlook/

User Image Harleybug Posted - 6 days ago

$CVKD pump and dump

User Image BHWinehouse Posted - 1 week ago

@Phil_the_bag I'm also in $CVKD and after their R/S it went up over 100%

User Image RealErnFranklin Posted - 1 week ago

$CVKD bounce again triple bottom in new range $Mi hell yea love this so much. Hong kong got paid, like real traders; not paid discord fakes $sint and $ktta folks staring at their screens for months. Someone pay me im good. 💡 $ZONE an actionable opportunity. Slap and trade it monday. Dont hold. Trade. It will get volume. All day. Bid, do whatever.

User Image Dazkusmoney Posted - 1 week ago

$CVKD Bounce you b*tch! This should be bottom. Or we risk falling below support.

User Image Cashcowtipper Posted - 1 week ago

$CVKD always

User Image bulltradrr Posted - 1 week ago

$CVKD

User Image Dazkusmoney Posted - 1 week ago

$CVKD https://s3.amazonaws.com/sec.irpass.cc/2774/0001213900-24-097866.htm

User Image Bigpaulbunyon Posted - 1 week ago

$CVKD the good thing for us Canadians is the exchange value is going up and up , I think just in exchange value I am up over 25 % since I first bought in . The bad thing everything else is gonna cost way more .

User Image JerryOLarry Posted - 1 week ago

$CVKD Low float stocks tend to have sizeable swings. You got to have the stomach to be able to endure these types of swings. Suck it up and relax.

User Image Dazkusmoney Posted - 1 week ago

$CVKD Should bounce again soon if following trend. Soon being before it goes below $16.

User Image Pharmbird Posted - 1 week ago

$CVKD 144% Always a blessing to actually call plays

Analyst Ratings
HC Wainwright & Co. Buy Jun 6, 24
HC Wainwright & Co. Buy May 9, 24
HC Wainwright & Co. Buy Mar 14, 24
Noble Capital Markets Outperform Dec 18, 23
HC Wainwright & Co. Buy Nov 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MURPHY JOHN RAYMOND Director Director Oct 04 Buy 0.7 20,000 14,000 614,792 10/06/23
Pham Quang X CEO and Chairman CEO and Chairman Sep 05 Buy 0.9 40,000 36,000 3,410,000 09/06/23
Pham Quang X CEO and Chairman CEO and Chairman Sep 01 Buy 0.91 70,000 63,700 3,370,000 09/05/23
MURPHY JOHN RAYMOND Director Director Mar 16 Buy 1.6699 20,000 33,398 574,792 03/16/23